Schedule 13G ownership disclosure

N/A

Common Stock · CUSIP: 78667J108

Event date: 2025-06-30

Filing-level shares
3,265,802
Percent of class
5.21%
  • The Vanguard Group

    Shares: 3,265,802 · Class: 5.21%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-001028
Form type
SCHEDULE 13G/A
Filer
Sage Therapeutics, Inc.
CIK
CIK 1597553
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub